Immature Myeloid Cells in Respiratory Syncytial Virus Bronchioliltis
NCT01684527 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 55
Last updated 2012-09-13
Summary
The investigators hypothesize that Respiratory Syncytial Virus (RSV) infection may influence the population of lung immature myeloid cells and dendritic cells in a way that will impair their ability to invoke an effective immune response and lead to prolonged inflammation, angiogenesis and scarring. This may lead in turn to disturbed lung function.
Our aim is to determine the presence and phenotype of immature myeloid cells present in respiratory secretions of children with RSV bronchiolitis as compared to non-RSV bronchiolitis and healthy controls.
Conditions
- Bronchiolitis
Interventions
- OTHER
-
Respiratory secretions obtained
Sponsors & Collaborators
-
Hillel Yaffe Medical Center
lead OTHER_GOV
Eligibility
- Max Age
- 2 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2014-01-31
- Completion
- 2014-01-31
Countries
- Israel
Study Locations
More Related Trials
-
Thymic Function in Patients With COVID-19
NCT04716907 ·Status: COMPLETED
-
This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction
NCT06853223 ·Status: RECRUITING ·Phase: PHASE2
-
Cyclin B1 Peptide-Pulsed Autologous Dendritic Cell Vaccine for Resectable Non-Small Cell Lung Cancer
NCT01398124 ·Status: WITHDRAWN ·Phase: NA
-
Impaired Immunity in Patients With Cancer: Influence of Cancer Stage, Chemotherapy, and Cytomegalovirus Infection
NCT00521287 ·Status: UNKNOWN ·Phase: PHASE2
-
Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients
NCT01394640 ·Status: COMPLETED
-
Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in Melanoma
NCT01456104 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Immune Signaling Networks in Healthy Human Volunteers
NCT01882582 ·Status: COMPLETED
-
T Cells Response to SARS COV 2 Peptides
NCT04573348 ·Status: UNKNOWN
-
Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19
NCT04457726 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Administration of Autologous Dendritic Cells (DCs) Infected With an Adenovirus Expressing Her-2
NCT00197522 ·Status: COMPLETED ·Phase: PHASE1
-
DC Vaccine Combined With CIK Cells in Patients With SCLC
NCT02688673 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Polyinosinic-Polycytidylic Acid-poly-L-lysine Carboxymethylcellulose (Poly-ICLC) in Healthy Volunteers
NCT01299662 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Systemically Administered Hydrocortisone on the Immune System in Healthy Volunteers
NCT01281995 ·Status: COMPLETED
-
Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer
NCT03515252 ·Status: COMPLETED ·Phase: PHASE1
-
Induction of Cytokines in Human Monocytes by SARS-CoV in Adults and Children
NCT00173563 ·Status: UNKNOWN
-
VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older
NCT01132859 ·Status: RECRUITING
-
In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients
NCT00001336 ·Status: COMPLETED
-
The Effects of Upper Airway and Digestive Tract Tumors on the Immune System
NCT00001603 ·Status: COMPLETED
-
A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)
NCT05809752 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
DCs Vaccine Combined With Cytokine-induced Killer Cells in Patients With AML
NCT01898663 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Natural Dendritic Cell Vaccines in Metastatic Melanoma Patients
NCT01690377 ·Status: COMPLETED ·Phase: PHASE1
-
Viral Specific T Cell Therapy for COVID-19 Related Pneumonia
NCT04742595 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Dendritic Cell Based Therapy of Metastatic Breast Cancer
NCT00197925 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Cellular Immunotherapy Study With Autologous Dendritic Cells Loaded With Oncofetal Antigen/iLRP in Patients With Metastatic Breast Cancer
NCT00879489 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19
NCT04324996 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2